EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects

Mohamed A A Abdelhamid iD, Mi-Ran Ki iD, Amer Ali Abd El-Hafeez iD, Ryeo Gang Son iD, Seung Pil Pack

Pharmaceutics · 03.01.2023 · 15 (1) · 168

DOI: 10.3390/pharmaceutics15010168 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 03.01.2023. Verfasst von Mohamed A A Abdelhamid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Environmental Industry and Technology Institute, National Research Foundation of Korea, Korea Environment Industry & Technology Institute (KEITI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, the potential use of nanoparticles for the targeted delivery of therapeutic and diagnostic agents has garnered increased interest. Several nanoparticle drug delivery systems have been developed for cancer treatment. Typically, protein-based nanocarriers offer several advantages, including biodegradability and biocompatibility. Using genetic engineering or chemical conjugation approaches, well-known naturally occurring protein nanoparticles can be further prepared, engineered, and functionalized in their self-assembly to meet the demands of clinical production efficiency. Accordingly, promising protein nanoparticles have been developed with outstanding tumor-targeting capabilities, ultimately overcoming multidrug resistance issues, in vivo delivery barriers, and mimicking the tumor microenvironment. Bioinspired by natural nanoparticles, advanced computational techniques have been harnessed for the programmable design of highly homogenous protein nanoparticles, which could open new routes for the rational design of vaccines and drug formulations. The current review aims to present several significant advancements made in protein nanoparticle technology, and their use in cancer therapy. Additionally, tailored construction methods and therapeutic applications of engineered protein-based nanoparticles are discussed.

Schlagwörter

Stichwörter der Autor:innen

cancer therapycontrolled releasedrug deliverynanocageprotein nanoparticlesself-assemblytargeting

Autor:innen und Institutionen

  • Department of Biotechnology and Bioinformatics, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea.
  • Department of Botany and Microbiology, Faculty of Science, Minia University, Minia 61519, Egypt.
  • Institute of Industrial Technology, Korea University, Sejong-Ro 2511, Sejong 30019, Republic of Korea.
  • Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt.

ORCID-Profile: Mohamed A A Abdelhamid, Mi-Ran Ki, Amer Ali Abd El-Hafeez, Ryeo Gang Son

Förderung

  • Korea Environmental Industry and Technology Institute
  • National Research Foundation of Korea
  • Korea Environment Industry & Technology Institute (KEITI)
  • Korea Ministry of Environment (MOE)
  • Korea University and the National Research Foundation of Korea (NRF)
  • Korean government (MSIT)

Zitieren

APA

Abdelhamid, M. A. A., Ki, M. R., Abd El-Hafeez, A. A., Son, R. G., & Pack, S. P. (2023). Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects. Pharmaceutics, 15(1), 168. https://doi.org/10.3390/pharmaceutics15010168

Vancouver

Abdelhamid MAA, Ki MR, Abd El-Hafeez AA, Son RG, Pack SP. Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects. Pharmaceutics. 2023;15(1):168. doi:10.3390/pharmaceutics15010168

BibTeX
@article{Abdelhamid2023,
  author = {Abdelhamid, Mohamed A A and Ki, Mi-Ran and Abd El-Hafeez, Amer Ali and Son, Ryeo Gang and Pack, Seung Pil},
  title = {Tailored Functionalized Protein Nanocarriers for Cancer Therapy: Recent Developments and Prospects},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {168},
  doi = {10.3390/pharmaceutics15010168}
}
Kostenlos starten →